PMID- 21184147 OWN - NLM STAT- MEDLINE DCOM- 20111005 LR - 20211020 IS - 1573-904X (Electronic) IS - 0724-8741 (Linking) VI - 28 IP - 6 DP - 2011 Jun TI - Controlled release of anti-inflammatory siRNA from biodegradable polymeric microparticles intended for intra-articular delivery to the temporomandibular joint. PG - 1370-84 LID - 10.1007/s11095-010-0354-9 [doi] AB - PURPOSE: As the next step in the development of an intra-articular controlled release system to treat painful temporomandibular joint (TMJ) inflammation, we developed several biodegradable poly(DL-lactic-co-glycolic acid) (PLGA)-based microparticle (MP) formulations encapsulating a model anti-inflammatory small interfering RNA (siRNA) together with branched poly(ethylenimine) (PEI) as a transfecting agent. The effect of siRNA loading and N:P ratio on the release kinetics of siRNA-PEI polyplexes was determined, and the size and N:P ratio of the polyplexes released over time was characterized. METHODS: Polyplex-loaded PLGA MPs were prepared using an established double emulsion technique. Increasing the pH of the release samples enabled siRNA-PEI dissociation and subsequent measurement of the release of each component over 28 days. Polyplex diameter was measured for all release samples and compared to freshly prepared siRNA-PEI under simulated physiologic conditions. RESULTS: Systematic variation of siRNA loading and N:P ratio resulted in distinct siRNA and PEI release profiles. Polyplex diameter remained constant despite large variations in the relative amounts of siRNA and PEI. Excess PEI was sequestered through complexation with 500-1,000 nm diameter PLGA MP-derived particles, including small MPs and PLGA degradation products. CONCLUSIONS: These PLGA MP formulations show exciting potential as the first intra-articular TMJ controlled release system. FAU - Mountziaris, Paschalia M AU - Mountziaris PM AD - Department of Bioengineering, Rice University, PO Box 1892, MS 142, Houston, Texas 77251-1892, USA. FAU - Sing, David C AU - Sing DC FAU - Chew, Sue Anne AU - Chew SA FAU - Tzouanas, Stephanie N AU - Tzouanas SN FAU - Lehman, E Dennis AU - Lehman ED FAU - Kasper, F Kurtis AU - Kasper FK FAU - Mikos, Antonios G AU - Mikos AG LA - eng GR - 5 T32 GM008362-19/GM/NIGMS NIH HHS/United States GR - 5 T90 DK070121-04/DK/NIDDK NIH HHS/United States GR - R01 DE17441/DE/NIDCR NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural DEP - 20101224 PL - United States TA - Pharm Res JT - Pharmaceutical research JID - 8406521 RN - 0 (Anti-Inflammatory Agents) RN - 0 (Delayed-Action Preparations) RN - 0 (Emulsions) RN - 0 (Imines) RN - 0 (Polyethylenes) RN - 0 (RNA, Small Interfering) RN - 0 (poly(ethylene imine)) RN - 1SIA8062RS (Polylactic Acid-Polyglycolic Acid Copolymer) RN - 26009-03-0 (Polyglycolic Acid) RN - 33X04XA5AT (Lactic Acid) SB - IM MH - Absorbable Implants MH - Anti-Inflammatory Agents/administration & dosage/chemistry MH - Chemistry, Pharmaceutical/methods MH - Delayed-Action Preparations MH - Emulsions MH - Hydrogen-Ion Concentration MH - Imines/administration & dosage/*chemistry MH - Injections, Intra-Articular MH - Kinetics MH - Lactic Acid/administration & dosage/*chemistry MH - *Microspheres MH - Osteitis/genetics/*therapy MH - Particle Size MH - Polyethylenes/administration & dosage/*chemistry MH - Polyglycolic Acid/administration & dosage/*chemistry MH - Polylactic Acid-Polyglycolic Acid Copolymer MH - RNA, Small Interfering/administration & dosage/*chemistry MH - Temporomandibular Joint EDAT- 2010/12/25 06:00 MHDA- 2011/10/06 06:00 CRDT- 2010/12/25 06:00 PHST- 2010/11/01 00:00 [received] PHST- 2010/12/14 00:00 [accepted] PHST- 2010/12/25 06:00 [entrez] PHST- 2010/12/25 06:00 [pubmed] PHST- 2011/10/06 06:00 [medline] AID - 10.1007/s11095-010-0354-9 [doi] PST - ppublish SO - Pharm Res. 2011 Jun;28(6):1370-84. doi: 10.1007/s11095-010-0354-9. Epub 2010 Dec 24.